UA91250C2 - 4-oxadiazolyl-piperidine compounds and use thereof - Google Patents

4-oxadiazolyl-piperidine compounds and use thereof

Info

Publication number
UA91250C2
UA91250C2 UAA200808315A UAA200808315A UA91250C2 UA 91250 C2 UA91250 C2 UA 91250C2 UA A200808315 A UAA200808315 A UA A200808315A UA A200808315 A UAA200808315 A UA A200808315A UA 91250 C2 UA91250 C2 UA 91250C2
Authority
UA
Ukraine
Prior art keywords
oxadiazolyl
piperidine compounds
piperidine
compounds
diarrhoea
Prior art date
Application number
UAA200808315A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Лейки Тафессе
Original Assignee
Пердью Фарма Л.П.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пердью Фарма Л.П. filed Critical Пердью Фарма Л.П.
Publication of UA91250C2 publication Critical patent/UA91250C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

4-Oxadiazolyl-piperidine compounds of formula (I) and (II), their compositions and use for the treatment of pain and diarrhoea., (I), (II)
UAA200808315A 2005-11-21 2006-11-21 4-oxadiazolyl-piperidine compounds and use thereof UA91250C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73910705P 2005-11-21 2005-11-21

Publications (1)

Publication Number Publication Date
UA91250C2 true UA91250C2 (en) 2010-07-12

Family

ID=37898486

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200808315A UA91250C2 (en) 2005-11-21 2006-11-21 4-oxadiazolyl-piperidine compounds and use thereof

Country Status (23)

Country Link
US (1) US20080319020A1 (en)
EP (3) EP2298764A1 (en)
JP (1) JP4991746B2 (en)
KR (1) KR20080080138A (en)
CN (1) CN101312964A (en)
AT (1) ATE547414T1 (en)
AU (1) AU2006314730B2 (en)
BR (1) BRPI0619679A2 (en)
CA (1) CA2628750C (en)
CY (1) CY1112773T1 (en)
DK (1) DK1951718T3 (en)
EA (1) EA013510B1 (en)
ES (1) ES2382712T3 (en)
HR (1) HRP20120434T2 (en)
NO (1) NO20082752L (en)
NZ (1) NZ568430A (en)
PL (1) PL1951718T3 (en)
PT (1) PT1951718E (en)
RS (1) RS52258B (en)
SI (1) SI1951718T1 (en)
UA (1) UA91250C2 (en)
WO (1) WO2007057229A1 (en)
ZA (1) ZA200803101B (en)

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
BE775611A (en) 1970-11-24 1972-03-16 Synthelabo DERIVATIVES OF (DIPHENYL-3,3 PROPYL-1) -1 PIPERIDINE, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING IT
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US3966748A (en) * 1975-05-08 1976-06-29 American Cyanamid Company Para-fluorophenyl-N-heterocyclic substituted butanes
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (en) 1989-03-22 1991-07-25 Bioresearch Spa USE OF 5 METHYLTHETRAHYDROPHOLIC ACID, 5 FORMYLTHETRAHYDROPHOLIC ACID AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS IN THE FORM OF CONTROLLED RELEASE ACTIVE IN THE THERAPY OF MENTAL AND ORGANIC DISORDERS.
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5698155A (en) 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
US5717947A (en) * 1993-03-31 1998-02-10 Motorola, Inc. Data processing system and method thereof
IT1270594B (en) 1994-07-07 1997-05-07 Recordati Chem Pharm CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION OF LIQUID SUSPENSION MOGUISTEIN
EP0833622B8 (en) * 1995-06-12 2005-10-12 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6573282B1 (en) * 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
CA2324330A1 (en) 1999-11-08 2001-05-08 Ssp Co., Ltd. 4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same
EP1277737A4 (en) * 2000-03-24 2003-05-07 Meiji Seika Kaisha Diphenylalkylamine derivatives useful as opioid delta receptor agonists
AU2002226000A1 (en) 2000-11-13 2002-05-21 Atrix Laboratories, Inc. Injectable sustained release delivery system with loperamide
US7202259B2 (en) * 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
US7208601B2 (en) * 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
CA2632643A1 (en) * 2005-12-08 2007-06-14 Pfizer Limited Chemical compounds
US20090012101A1 (en) * 2005-12-27 2009-01-08 University Of Toledo Mucarinic Agonists and Methods of Use Thereof

Also Published As

Publication number Publication date
PT1951718E (en) 2012-05-21
ES2382712T3 (en) 2012-06-12
CA2628750A1 (en) 2007-05-24
NO20082752L (en) 2008-08-06
RS52258B (en) 2012-10-31
AU2006314730B2 (en) 2011-02-03
EP1951718B1 (en) 2012-02-29
EA013510B1 (en) 2010-06-30
JP4991746B2 (en) 2012-08-01
HRP20120434T1 (en) 2012-06-30
EA200801392A1 (en) 2008-10-30
EP2298764A1 (en) 2011-03-23
HRP20120434T2 (en) 2012-11-30
PL1951718T3 (en) 2012-08-31
US20080319020A1 (en) 2008-12-25
EP2298765A1 (en) 2011-03-23
SI1951718T1 (en) 2012-06-29
NZ568430A (en) 2011-02-25
AU2006314730A1 (en) 2007-05-24
ZA200803101B (en) 2009-03-25
JP2009516664A (en) 2009-04-23
CA2628750C (en) 2013-02-12
CY1112773T1 (en) 2016-02-10
DK1951718T3 (en) 2012-05-14
ES2382712T9 (en) 2012-10-30
WO2007057229A1 (en) 2007-05-24
EP1951718B9 (en) 2012-08-15
BRPI0619679A2 (en) 2011-10-11
EP1951718A1 (en) 2008-08-06
KR20080080138A (en) 2008-09-02
ATE547414T1 (en) 2012-03-15
CN101312964A (en) 2008-11-26

Similar Documents

Publication Publication Date Title
TW200716606A (en) Chemical compounds
TW200800963A (en) Chemical compounds
HK1113352A1 (en) Chemical compounds
HK1114375A1 (en) Chemical compounds
PT1984357E (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
TW200626068A (en) Active compounds for seed treatment
TW200738659A (en) Novel compounds
MX2009008347A (en) Oxabicycloheptanes and oxabicycloheptenes, their preparation and use.
MY153915A (en) Organic compounds
TW200630367A (en) Substituted adenines and the uses thereof
UA85559C2 (en) Aminobenzophenone compounds
TW200700064A (en) Novel compounds
TW200716088A (en) Formulations and methods for treating amyloidosis
WO2007120333A3 (en) Tetracyclic kinase inhibitors
IL190730A0 (en) Potassium channel inhibitors
TW200744612A (en) New combination
MX2008001428A (en) Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders.
TW200621260A (en) Selected fused heterocyclics and uses thereof
MX2010001303A (en) Therapeutic compounds.
MY148651A (en) Antitumoral compounds
EA200901179A1 (en) SUBSTITUTED TETRAHYDROCHINOLINES
TW200738244A (en) 20-Alkyl, gemini vitamin D3 compounds and methods of use thereof
MY145765A (en) Anthracenedione compounds
UA91250C2 (en) 4-oxadiazolyl-piperidine compounds and use thereof
TW200615274A (en) Chemical compounds